Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceuti... Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. 더 보기
WALTHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will...
WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial...
BioLife Solutions Appoints Tony J. Hunt to its Board of Directors PR Newswire BOTHELL, Wash., Dec. 16, 2024 BOTHELL, Wash., Dec. 16, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq:...
WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital...
WALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.54 | -0.918032786885 | 167.75 | 181.66 | 163.9 | 729143 | 169.86207674 | CS |
4 | 22.35 | 15.5359377172 | 143.86 | 181.66 | 142.38 | 625348 | 162.55656348 | CS |
12 | 23.17 | 16.1982662192 | 143.04 | 181.66 | 121.52 | 613410 | 149.55276863 | CS |
26 | 5.24 | 3.2552649562 | 160.97 | 181.66 | 121.52 | 666986 | 148.56124885 | CS |
52 | -25.84 | -13.4548294715 | 192.05 | 211.13 | 113.5 | 641071 | 153.11792406 | CS |
156 | -25.58 | -13.3375045623 | 191.79 | 262.26 | 110.45 | 592660 | 165.74979104 | CS |
260 | 64.62 | 63.608622896 | 101.59 | 327.32 | 78.41 | 535245 | 169.69968 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관